genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2024

Protein degradation

Gee WIZ: Novartis’ “Glue Degrader” Drug Candidate for Sickle Cell Shows Promise in Animal Studies
GEN Edge

Gee WIZ: Novartis’ “Glue Degrader” Drug Candidate for Sickle Cell Shows Promise in Animal Studies

AACR 2024: EpiBiologics Advances Degraders of Membrane-Bound Proteins
Cancer

AACR 2024: EpiBiologics Advances Degraders of Membrane-Bound Proteins

How Innate Immunity Is Regulated
News

How Innate Immunity Is Regulated

Protein Degradation and Particle Formation Control Strategies
Bioprocessing

Protein Degradation and Particle Formation Control Strategies

Targeted Protein Degradation: A Promising Option for Cancer Drug Developers
Cancer

Targeted Protein Degradation: A Promising Option for Cancer Drug Developers

Alzheimer’s Model Mice Treated Using Targeted Protein Degradation
News

Alzheimer’s Model Mice Treated Using Targeted Protein Degradation

CMS Enables Standard-Free Quantitation of Protein Therapeutics
Bioprocessing

CMS Enables Standard-Free Quantitation of Protein Therapeutics

Protein-Degradation CELMoD Drug Prospects Aided by New Study Findings
Cancer

Protein-Degradation CELMoD Drug Prospects Aided by New Study Findings

DMPK Optimization of Proteolysis-Targeting Chimeras
Drug Discovery

DMPK Optimization of Proteolysis-Targeting Chimeras

Novartis Jumpstarts Presence in Protein Degradation with Up-to-$1.3B Dunad Collaboration
Drug Discovery

Novartis Jumpstarts Presence in Protein Degradation with Up-to-$1.3B Dunad Collaboration

123Page 1 of 3

Read the Digital Edition

June 2024 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up